Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Asthma in the era of COVID-19

Assaf, Sara ; Stenberg, Henning ; Jesenak, Milos ; Tarasevych, Svitlana P. ; Hanania, Nicola A. and Diamant, Zuzana LU (2023) In Respiratory Medicine 218.
Abstract

Since its global invasion in 2019, COVID-19 has affected several aspects of patients’ lives and posed a significant impact on the health care system. Several patient populations were identified to be at high risk of contracting SARS-CoV-2 infection and/or developing severe COVID-19-related sequelae. Conversely, anyone who has contracted SARS-CoV-2 is at risk to experience symptoms and signs consistent with post-COVID manifestations. Patients with asthma were initially thought to be at increased risk and severity for SARS-CoV-2 infection. However, accumulating evidence demonstrates that asthma endotypes/phenotypes and comorbidities influence the risk stratification in this population. Furthermore, initial concerns about the potentially... (More)

Since its global invasion in 2019, COVID-19 has affected several aspects of patients’ lives and posed a significant impact on the health care system. Several patient populations were identified to be at high risk of contracting SARS-CoV-2 infection and/or developing severe COVID-19-related sequelae. Conversely, anyone who has contracted SARS-CoV-2 is at risk to experience symptoms and signs consistent with post-COVID manifestations. Patients with asthma were initially thought to be at increased risk and severity for SARS-CoV-2 infection. However, accumulating evidence demonstrates that asthma endotypes/phenotypes and comorbidities influence the risk stratification in this population. Furthermore, initial concerns about the potentially increased risk of poor outcomes with asthma treatments such as inhaled corticosteroids and biologics have not been substantiated. In this review, we provide an update on COVID-19 and asthma, including risk of susceptibility, clinical manifestations and course in this population as well as discuss recommendations for management.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Asthma, Biologicals, COVID-19, Long COVID, Phenotypes
in
Respiratory Medicine
volume
218
article number
107373
publisher
Elsevier
external identifiers
  • pmid:37567514
  • scopus:85170097023
ISSN
0954-6111
DOI
10.1016/j.rmed.2023.107373
language
English
LU publication?
yes
id
1385fc3c-a99c-4f3d-9f91-deb95b7117eb
date added to LUP
2023-10-20 16:15:20
date last changed
2024-04-19 02:41:30
@article{1385fc3c-a99c-4f3d-9f91-deb95b7117eb,
  abstract     = {{<p>Since its global invasion in 2019, COVID-19 has affected several aspects of patients’ lives and posed a significant impact on the health care system. Several patient populations were identified to be at high risk of contracting SARS-CoV-2 infection and/or developing severe COVID-19-related sequelae. Conversely, anyone who has contracted SARS-CoV-2 is at risk to experience symptoms and signs consistent with post-COVID manifestations. Patients with asthma were initially thought to be at increased risk and severity for SARS-CoV-2 infection. However, accumulating evidence demonstrates that asthma endotypes/phenotypes and comorbidities influence the risk stratification in this population. Furthermore, initial concerns about the potentially increased risk of poor outcomes with asthma treatments such as inhaled corticosteroids and biologics have not been substantiated. In this review, we provide an update on COVID-19 and asthma, including risk of susceptibility, clinical manifestations and course in this population as well as discuss recommendations for management.</p>}},
  author       = {{Assaf, Sara and Stenberg, Henning and Jesenak, Milos and Tarasevych, Svitlana P. and Hanania, Nicola A. and Diamant, Zuzana}},
  issn         = {{0954-6111}},
  keywords     = {{Asthma; Biologicals; COVID-19; Long COVID; Phenotypes}},
  language     = {{eng}},
  publisher    = {{Elsevier}},
  series       = {{Respiratory Medicine}},
  title        = {{Asthma in the era of COVID-19}},
  url          = {{http://dx.doi.org/10.1016/j.rmed.2023.107373}},
  doi          = {{10.1016/j.rmed.2023.107373}},
  volume       = {{218}},
  year         = {{2023}},
}